Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours
| Autor: | Perotti, A. 1, Sessa, C. 2, Mancuso, A. 2, Noberasco, C. 3, Cresta, S. 1, Locatelli, A. 1, Carcangiu, M.L. 1, Passera, K. 4, Braghetti, A. 2, Scaramuzza, D. 1, Zanaboni, F. 1, Fasolo, A. 1, Capri, G. 1, Miani, M. 5, Peters, W.P. 6, Gianni, L. 1, * |
|---|---|
| Zdroj: | In Annals of Oncology April 2009 20(4):741-745 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|